TY - JOUR T1 - Development and Implementation of a Simple and Rapid Extraction-Free Saliva SARS-CoV-2 RT-LAMP Workflow for Workplace Surveillance JF - medRxiv DO - 10.1101/2022.03.11.22272282 SP - 2022.03.11.22272282 AU - Zhiru Li AU - Jacqueline L. Bruce AU - Barry Cohen AU - Caileigh V. Cunningham AU - William E. Jack AU - Katell Kunin AU - Bradley W. Langhorst AU - Jacob Miller AU - Reynes A. Moncion AU - Catherine B. Poole AU - Prem K. Premsrirut AU - Guoping Ren AU - Richard J. Roberts AU - Nathan A. Tanner AU - Yinhua Zhang AU - Clotilde K. S. Carlow Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/03/13/2022.03.11.22272282.abstract N2 - Effective management of the COVID-19 pandemic requires widespread and frequent testing of the population for SARS-CoV-2 infection. Saliva has emerged as an attractive alternative to nasopharyngeal samples for surveillance testing as it does not require specialized personnel or materials for its collection and can be easily provided by the patient. We have developed a simple, fast, and sensitive saliva-based testing workflow that requires minimal sample treatment and equipment. After sample inactivation, RNA is quickly released and stabilized in an optimized buffer, followed by reverse transcription loop-mediated isothermal amplification (RT-LAMP) and detection of positive samples using a colorimetric and/or fluorescent readout. The workflow was optimized using 1,670 negative samples collected from 172 different individuals over the course of 6 months. Each sample was spiked with 50 copies/μL of inactivated SARS-CoV-2 virus to monitor the efficiency of viral detection. Using pre-defined clinical samples, the test was determined to be 100% specific and 97% sensitive, with a limit of detection comparable to commercially available RT-qPCR-based diagnostics. The method was successfully implemented in a CLIA laboratory setting for workplace surveillance and reporting. From April 2021-February 2022, more than 30,000 self-collected samples from 755 individuals were tested and 85 employees tested positive mainly during December and January, consistent with high infections rates in Massachusetts and nationwide. The rapid identification and isolation of infected individuals with trace viral loads before symptom onset minimized viral spread in the workplace.Competing Interest StatementNew England Biolabs (www.neb.com) has funded this study. All authors (ZL,JLB, BC, CVC, WEJ, KK, BWL, JB, RAM, CBP, GR, RJR, NAT, YZ and CKSC) are employees and shareholders of New England Biolabs, manufacturer of LAMP and PCR reagents described in the manuscriptFunding StatementThis study was funded by New England Biolabs.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board (IRB)of WCG/New England Biolabs gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. ER -